Cargando…

Cancer Patient Tissueoid with Self‐Homing Nano‐Targeting of Metabolic Inhibitor

Mostrar otras versiones (1)

The current paradigm of cancer medicine focuses on patient‐ and/or cancer‐specific treatments, which has led to continuous progress in the development of patient representatives (e.g., organoids) and cancer‐targeting carriers for drug screening. As breakthrough concepts, i) living cancer tissues con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Hyo‐Jin, Chung, Young Shin, Lee, Yong Jae, Yu, Seung Eun, Baek, Sewoom, Kim, Hye‐Seon, Kim, Sang Wun, Lee, Jung‐Yun, Kim, Sunghoon, Sung, Hak‐Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596099/ https://www.ncbi.nlm.nih.gov/pubmed/34664430 http://dx.doi.org/10.1002/advs.202102640

Ejemplares similares

Cancer Patient Tissueoid with Self‐Homing Nano‐Targeting of Metabolic Inhibitor
por: Yoon, Hyo‐Jin, et al.
Publicado: (2021)

Body-Shaping Membrane to Regenerate Breast Fat by Elastic Structural Holding
por: Kim, Hye-Seon, et al.
Publicado: (2023)

O(2) variant chip to simulate site-specific skeletogenesis from hypoxic bone marrow
por: Kim, Hye-Seon, et al.
Publicado: (2023)

Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions
por: Yoon, Hyo-Jin, et al.
Publicado: (2021)

Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study
por: Seon, Ki Eun, et al.
Publicado: (2023)

Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center
por: Lee, Yong Jae, et al.
Publicado: (2018)

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

Sprayable nanomicelle hydrogels and inflammatory bowel disease patient cell chips for development of intestinal lesion-specific therapy
por: Yoon, Hyo-Jin, et al.
Publicado: (2022)

Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
por: Lee, Yong Jae, et al.
Publicado: (2022)

In-bag power morcellation technique in single-port laparoscopic myomectomy
por: Won, Young Bin, et al.
Publicado: (2018)

Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score
por: Park, Seon Hee, et al.
Publicado: (2018)

Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
por: Lee, Yong Jae, et al.
Publicado: (2018)

Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis
por: Lee, Dahye, et al.
Publicado: (2023)

Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Lee, Yong Jae, et al.
Publicado: (2020)

Delayed hemorrhage effect of local anesthesia with epinephrine in the loop electrosurgical excisional procedure
por: Lee, Yong Jae, et al.
Publicado: (2017)

Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer
por: Kim, Yun-Ji, et al.
Publicado: (2018)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017)

Clinical Significance of Microsatellite Instability in Sporadic Epithelial Ovarian Tumors
por: Yoon, Bo-Sung, et al.
Publicado: (2008)

Vascular Cast to Program Antistenotic Hemodynamics and Remodeling of Vein Graft
por: Ha, Hyunsu, et al.
Publicado: (2023)

A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution
por: Nam, Seon Mi, et al.
Publicado: (2017)

A comparison of clinical and surgical outcomes between laparo-endoscopic single-site surgery and traditional multiport laparoscopic surgery for adnexal tumors
por: Lee, In Ok, et al.
Publicado: (2014)

Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations
por: Cabiscuelas, Charmaine A., et al.
Publicado: (2021)

Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47
por: Lee, Yong-Jae, et al.
Publicado: (2022)

Pelvic malakoplakia presenting as endometrial cancer: a case report
por: Cho, Jeong Soo, et al.
Publicado: (2020)

ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2014)

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
por: Lee, Jung-Yun, et al.
Publicado: (2017)

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
por: Kim, Yoo-Na, et al.
Publicado: (2019)

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2020)

Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue
por: Nam, Eun Ji, et al.
Publicado: (2016)

MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
por: Nam, Eun Ji, et al.
Publicado: (2012)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
por: Lee, Yong Jae, et al.
Publicado: (2018)

Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer
por: Kwak, Young Hwa, et al.
Publicado: (2022)

Prognostic value of complete metabolic response on (18)F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2022)

Sentinel lymph node mapping with indocyanine green in vaginal cancer
por: Lee, In Ok, et al.
Publicado: (2017)

Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim's technique and comparison to laparotomy
por: Kim, Jeong Sook, et al.
Publicado: (2017)

Microchannel network hydrogel induced ischemic blood perfusion connection
por: Lee, Jung Bok, et al.
Publicado: (2020)

In Vitro Anti-Inflammatory and Antioxidant Activities of pH-Responsive Resveratrol-Urocanic Acid Nano-Assemblies
por: Song, Heegyeong, et al.
Publicado: (2023)

Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis
por: Cho, Sang Hyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b5plh6m4dm4hosgn919iocckps